Immediate Impact
1 by Nobel laureates 2 from Science/Nature 59 standout
Citing Papers
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
2023 Standout
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Works of Robin K. Dore being referenced
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial
2008
Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robin K. Dore | 503 | 650 | 707 | 617 | 31 | 1.5k | |
| Michael D. Fallon | 464 | 509 | 617 | 639 | 57 | 2.0k | |
| Deborah Wenkert | 595 | 456 | 640 | 585 | 45 | 1.9k | |
| S Bord | 322 | 630 | 461 | 1068 | 30 | 2.0k | |
| Linda R. Halstead | 216 | 522 | 496 | 827 | 38 | 2.1k | |
| D. Wattie | 330 | 1098 | 1083 | 576 | 37 | 2.1k | |
| Christian Rosenquist | 314 | 489 | 427 | 410 | 17 | 1.5k | |
| Osvaldo Daniel Messina | 405 | 375 | 498 | 333 | 51 | 1.2k | |
| Giuseppe Girasole | 206 | 638 | 580 | 792 | 21 | 1.7k | |
| Laura Masi | 236 | 483 | 751 | 717 | 59 | 1.8k | |
| Ulrike I. Mödder | 139 | 574 | 727 | 922 | 24 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...